REPLIGEN CORP (RGEN) Capital expenditures 2016–2025
REPLIGEN CORP (RGEN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$23.5MFY2025 · since FY2016: $4.3M → $23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $23.5M | -8.4% |
| FY2024 | $25.7M | -29.1% |
| FY2023 | $36.2M | -57.3% |
| FY2022 | $84.8M | +26.4% |
| FY2021 | $67.1M | +198.8% |
| FY2020 | $22.5M | +21.4% |
| FY2019 | $18.5M | +74.0% |
| FY2018 | $10.6M | +95.0% |
| FY2017 | $5.5M | +26.1% |
| FY2016 | $4.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice